383 results on '"Jarnagin W."'
Search Results
2. The Effect of Histopathological Growth Patterns of Colorectal Liver Metastases on the Survival Benefit of Adjuvant Hepatic Arterial Infusion Pump Chemotherapy
3. Abstract No. 121 Vascular Emergencies in Patients with Hepatic Arterial Infusion Pumps: A Single-Center Retrospective Study
4. The margin debate revisited: genomic predictors of R0 resection following pancreatoduodenectomy
5. One-year mortality after hepatectomy: defining a novel quality metric
6. GENOMIC classifier aligns most pancreatic acinar carcinoma with pancreatic ductal adenocarcinoma
7. Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE
8. The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE
9. Postoperative Mortality and Survival after Resection of Perihilar Cholangiocarcinoma; Left Hepatectomy Is Preferred When Possible
10. Staging Systems
11. A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases
12. Rates and Patterns of Recurrence after Microwave Ablation of Colorectal Liver Metastases: A Per-Lesion Analysis of 416 Tumors in the Era of 2.45GHz Generators
13. Distinct KRAS Mutations are Enriched in Early-Stage Resected Pancreatic Ductal Adenocarcinoma
14. Persistent Disparities in Treatment and Survival for Patients with Pancreatic Cancer Despite Insurance Expansion Policies
15. Association Between Biopsy Method and Development of Peritoneal Metastases in Perihilar Cholangiocarcinoma
16. Correction to: Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma (Annals of Surgical Oncology, (2020), 10.1245/s10434-020-08258-3)
17. Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma
18. Port-Site Resection in the Surgical Management of Incidental Gallbladder Cancer: A Still Inconclusive Question: A Reply
19. Survival after resection of perihilar cholangiocarcinoma—development and external validation of a prognostic nomogram
20. Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer
21. Long-term outcomes following microwave ablation for liver malignancies
22. Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases
23. Hepatic Arterial Nodal Metastases in Pancreatic Cancer: Is This the Node of Importance?
24. Malignant Progression in IPMN: A Cohort Analysis of Patients Initially Selected for Resection or Observation
25. Downstaging in Pancreatic Cancer: A Matched Analysis of Patients Resected Following Systemic Treatment of Initially Locally Unresectable Disease
26. Prospective Study of Outcomes after Percutaneous Biliary Drainage for Malignant Biliary Obstruction
27. Abstract No. 26 Combined portal vein and hepatic vein embolization in heavily pretreated colorectal cancer patients undergoing major hepatic resection: experience in a single cancer US center
28. Abstract No. 223 Liquid versus non-liquid (particles) embolic agents in portal vein embolization prior to major liver resection: comparison of volumetric and clinical outcomes
29. Rates and Patterns of Recurrence for Percutaneous Radiofrequency Ablation and Open Wedge Resection for Solitary Colorectal Liver Metastasis
30. Prospective, Blinded Comparison of Helical CT and CT Arterial Portography in the Assessment of Hepatic Metastasis from Colorectal Carcinoma
31. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy
32. Initial experience with hand-assisted laparoscopic distal pancreatectomy
33. Ablative Radiation Provides Comparable 1-year Survival to Surgery after Neoadjuvant Chemotherapy for Locally Advanced Pancreatic Adenocarcinoma
34. Robotic assisted right posterior sectionectomy
35. Association between biopsy method and development of peritoneal metastases in perihilar cholangiocarcinoma
36. Pre-operative colorectal liver metastasis resection margin assessment by the surgeon: a prospective study
37. The role of radiomics in predicting early liver recurrence after resection of intrahepatic cholangiocarcinoma
38. Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection
39. The Role of Staging Laparoscopy in Hepatobiliary Malignancy: Prospective Analysis of 401 Cases
40. Staging laparoscopy for potentially resectable noncolorectal, nonneuroendocrine liver metastases
41. MANAGEMENT OF HEPATOCELLULAR ADENOMA: COMPARISON OF OBSERVATION, EMBOLIZATION, AND RESECTION: BF076
42. VASCULAR INFLOW CONTROL DURING HEPATIC LOBECTOMY: A COMPARISON OF INTRAHEPATIC PEDICLE LIGATION AND EXTRAHEPATIC LIGATION: PL23
43. HEPATIC ARTERIAL NODAL METASTASES IN PANCREATIC CANCER: IS THIS THE NODE OF IMPORTANCE?
44. Margin of the largest tumor predicts post-surgery survival of multitumor colorectal liver metastases
45. Cross-fellowship inter-institutional exchange: A new paradigm in hepatobiliary surgery training
46. Ablative Radiation Therapy (RT) Doses in Hepatocellular Carcinoma (HCC): Impact on Local Control, Survival, and Tumor-related Liver Failure
47. Portal vein embolization before liver resection for perihilar cholangiocarcinoma reduces the risk of liver failure and perioperative mortality
48. Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival
49. Gallbladder Cancer (GBC): 10-Year Experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)
50. Liver resection after hepatic arterial infusion (HAI) plus systemic oxaliplatin (Oxal) combinations in pretreated patients with extensive unresectable colorectal liver metastases: 3542
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.